Akari Therapeutics ADR (AKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Operating Expenses | 7,826 | 3,117 | 6,031 | -12 | 4,721 |
| Operating Income | -7,826 | -3,117 | -6,031 | 12 | -4,721 |
| Other Income | 208 | 552 | 1,914 | -2,557 | 1,209 |
| Pre-tax Income | -7,619 | -2,565 | -4,117 | -2,545 | -3,513 |
| Net Income Continuous | -7,619 | -2,565 | -4,117 | -2,545 | -3,513 |
| Net Income | $-7,619 | $-2,565 | $-4,117 | $-2,545 | $-3,513 |
| EPS Basic Total Ops | -14.88 | 0.00 | -5.12 | 0.00 | N/A |
| EPS Basic Continuous Ops | -7.45 | -2.60 | -5.12 | -3.22 | -4.41 |
| EPS Diluted Total Ops | -14.88 | 0.00 | -5.12 | 0.00 | N/A |
| EPS Diluted Continuous Ops | -7.45 | -2.60 | -5.12 | -3.22 | -4.41 |
| EBITDA(a) | $-22,699 | $11,764 | $-6,027 | $18 | $-4,714 |